MDCX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Medicus Pharma Ltd (MDCX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks significant positive catalysts, financial growth is weak, and there are no strong trading signals or insider activity to suggest immediate upside potential. Holding off for now is advisable.
The MACD is positive and expanding, indicating a potential upward momentum. However, the RSI is neutral at 76.66, and moving averages are converging, suggesting no clear trend. The pre-market price of 1.39 is above the R1 resistance level of 1.333, which may indicate overbought conditions.
The MACD histogram is positive and expanding, suggesting potential upward momentum in the short term.
No recent news or significant insider or hedge fund activity. Financial performance remains weak with negative net income and EPS. The RSI is neutral, and moving averages show no clear trend.
In 2025/Q3, the company's revenue remained stagnant at 0 (0.00% YoY growth). Net income improved to -20,935,753, up 818.74% YoY but still negative. EPS increased to -1.12, up 366.67% YoY, but remains in the negative territory. Gross margin is 0, showing no profitability.
No data available for analyst ratings or price target changes.
